Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Revenue $ 30,302 $ 21,388 $ 84,031 $ 56,123
Cost of revenue 12,868 9,214 35,693 24,503
Gross profit 17,434 12,174 48,338 31,620
Operating expenses:        
Sales and marketing 16,021 8,882 42,475 28,699
Research and development 6,195 5,414 19,902 14,354
General and administrative 9,131 8,024 22,717 19,048
Total operating expenses 31,347 22,320 85,094 62,101
Loss from operations (13,913) (10,146) (36,756) (30,481)
Other income (expense):        
Interest expense (303) (274) (876) (792)
Other income (expense) (4) 16 10 238
Net loss (14,220) (10,404) (37,622) (31,035)
Less: cumulative dividends on redeemable convertible preferred stock (585) (538) (1,691) (1,564)
Net loss attributable to common stock holders - basic $ (14,805) $ (10,942) $ (39,313) $ (32,599)
Net loss per share attributable to common stockholders - basic (in dollars per share) $ (1.03) $ (0.95) $ (2.97) $ (2.91)
Net loss per share attributable to common stockholders - diluted (in dollars per share) $ (1.03) $ (0.95) $ (2.97) $ (2.91)
Weighted-average common shares outstanding - basic (in shares) 14,317,575 11,521,625 13,250,767 11,214,369
Weighted-average common shares outstanding - diluted (in shares) 14,317,575 11,521,625 13,250,767 11,214,369